Links to other EMEUNET Sub-Committee Membership posts:
Tue Wenzel Kragstrup, MD, PhD
Tue is currently working as a part-time Associate Professor in immunology and pharmacology and a part-time rheumatology fellow in Aarhus and Silkeborg, Denmark (finishing training in Jan 2024). The Kragstrup lab focuses on the immunological mechanisms of inflammatory arthritis with special interest in building in vitro models and bioinformatics pipelines for drug discovery, target validation, personalized medicine and drug repurposing. Tue graduated from the medical school at Aarhus University in 2010, also spending time at Sydney University Hospital. He did his internship in Copenhagen and PhD at the Department of Biomedicine at Aarhus University and Department of Immunology at Stanford University. Tue is currently enrolled in the Personalized medicine masters program in Denmark. Tue is EULAR EMEUNET Committee Chair and was previously Danish Country Liaison, Working Group member and Education Subcommittee leader.
Kim Lauper, MD
Kim is a consultant rheumatologist and senior clinical associate at the Geneva University Hospitals in Switzerland, and a clinical research fellow at the Centre for Epidemiology Versus Arthritis at the University of Manchester in the UK. Her research focuses on rheumatoid arthritis, (pharmaco)-epidemiology, real-life evidence, vaccination and methodology of observational studies. She has contributed to the Rheumatoid Arthritis: Treatment chapter of the 16th and 17th EULAR Online Course on Rheumatic Diseases. She is a member of the Rheumatoid Arthritis scientific committee of the Swiss register of rheumatologic diseases (Swiss Clinical Quality Management in Rheumatic Diseases, SCQM). She is the Past-Chair of the EMEUNET Committee.
EMEUNET Sub-Committee Leadership Team
Diego Benavent, MD
Diego is a consultant rheumatologist at Hospital Universitario La Paz in Madrid, where he is currently doing his PhD on axial spondyloarthritis. He also collaborates as Medical Expert in Savana, a company working on artificial intelligence in medicine. Aside from his activities regarding healthcare technology, his major interests are spondyloarthritis, patient-reported outcomes and musculoskeletal epidemiology. Diego is the chair of the Newsletter Sub-Committee.
Alvise Berti, MD, PhD
Alvise Berti, MD, PhD, is an Assistant Professor in Rheumatology at University of Trento and a Consultant in the Rheumatology Unit, S. Chiara Hospital, Trento, Italy. He had the opportunity to work at Mayo Clinic (Rochester, MN, USA) during his education for a total of 2 years as VCRC-VF physician (Vasculitis Clinical Research Consortium – Vasculitis Foundation). In addition to his clinical work in the Rheumatology Unit, he conducts clinical and translational research within the field of Rheumatology, with a focus on autoimmune and inflammatory diseases, particularly in vasculitides and connective tissue diseases. Alvise is the chair of the Peer-Mentoring Sub-Committee.
Ertugrul Cagri Bolek, MD
Ertugrul received his M.D. and Internal Medicine specialist degrees from Hacettepe University, Ankara, Turkey. He is currently clinical fellow-in-training in the Division of Rheumatology at the same university. Also, he is simultaneously in the education program of Immunology MSc. His past work was about clinical features and disease course of Neuro-Behcet’s Disease. He is planning to focus on translational research about immuno-rheumatology and mechanisms of rheumatism (especially vasculitis and rare diseases). He is an active member of ORPHANET-Tr in Health Institutes of Turkey. Ertugrul is the chair of the Country Liaisons Sub-Committee.
Mrinalini Dey MB BChir, MA (Hons) Cantab, MRCP (Rheumatology), FHEA
Mrinalini Dey is an academic rheumatology registrar working in London, UK. She is the Co-Lead of the EMEUNET Social Media Subcommittee. She developed her interest in academic rheumatology as a student at the University of Cambridge and subsequently as an National Institute for Health and Research-funded Academic Clinical Fellow. Her research interests include epidemiology and the impact of socioeconomic factors and comorbidities in rheumatic diseases. Mrinalini is on the Editorial Board and social media committee for Rheumatology journal and is a previous presenter for EULAR TV at the EULAR Congress and RheumNow. She sits on the EULAR Advocacy and PARE Committees. From October 2023, Mrinalini will embark on a Clinical PhD at King’s College London, focussing on socioeconomic and comorbidity burden in inflammatory arthritis. Mrinalini is the co-chair of the Social Media Sub-Committee.
Latika Gupta, MD
Dr Gupta is a consultant rheumatologist and honorary senior lecturer working at the Royal Wolverhampton Hospitals NHS Trust and University of Manchester, UK, with an interest in myositis, equity and digital health. Dr Gupta currently serves as the IMACS mentorship lead and is the co-chair for EMEUNET social media and APLAR Young Rheumatology. Besides medical teaching, Dr Gupta enjoys travelling and photo painting. She is the co-chair of the Social Media Sub-Committee.
Daniele Mauro, MD, PhD
Daniele is a medical doctor who completed his PhD in Experimental Medicine and Rheumatology at the Centre for Experimental Medicine and Rheumatology at Queen Mary University of London (UK). He focused his study on the involvement of ubiquitination pathways on the immune system, and their impact on autoimmune rheumatic diseases, mainly systemic lupus erythematosus, Sjögren’s syndrome and rheumatoid arthritis. Since 2018, he has been a trainee in Rheumatology in Italy, where he is expanding his interests to the mucosal immunology and innate lymphoid cells in spondyloarthritis, working between the Universities of Palermo and Naples in Italy, and the Queen Mary University of London. Daniele is the chair of the Visibility & Global Affairs Sub-Committee.
Luis Fernando Perez, MD, MSc
Mexico, the Netherlands
Luis Fernando is academic rheumatologist and a PhD candidate at the Erasmus University Medical Center in Rotterdam, the Netherlands. His major interest is Reproductive Rheumatology, with an specific interest on the male perspective. He is participating in the development of national and international guidelines on the use of immunosuppressive treatment in female and male patients diagnosed with rheumatic diseases before conception, during pregnancy and during lactation. Luis Fernando is the leader of the Education sub-committee.